HOME Top Market Reports Global Breast Cancer Drugs Market

Global Breast Cancer Drugs Market

By: marketsandmarkets.com
Publishing Date: June 2014
Report Code: PH 1244

Discount on Prebooks  

Enquiry Before Buying
 
purchase report
download pdf  request for customisation


INTRODUCTION

  • To define global breast cancer drugs market.
  • To analyze the existing drugs with respect to their competitive advantage and adverse effects
  • To understand the ongoing clinical trails and provide pipeline analysis
  • To understand and analyze the regulatory framework , clinical data related to drug efficacy and safety
  • To identify and analyze the unmet needs and the emerging opportunities in the breast cancer drug market
  • To identify and analyze comprehensively the market structure with respect to the factors influencing the market growth and industry specific challenges.
  • To identify the major drivers and restraints of the market
  • To analyze and forecast revenues of market segments with respect to geographies (North America, Europe, Asia & Rest of the World).
  • To strategically profile and analyze market players and their core competencies in the field of breast cancer drugs for each of its market segment.
  • To track and analyse recent developments, alliances, joint ventures, mergers & acquisitions that has an impact on breast cancer drugs market.

REPORT DESCRIPTION

There are about one million new cases of breast cancer every year. Breast cancer accounts for about 10% of world wide cancer. There has been significant increase in awareness levels with respect to impact on survival rates incase of early diagnosis. Therefore, opening novel opportunities for breast cancer drugs market. The market has several products for breast cancer treatment such as, hormonal therapies, chemotherapies, combinations and targeted therapies, etc. However, unmet needs with respect to severe adverse effects and unconvincing safety data associated with these treatments are therefore, enhancing opportunities for market expansion of novel drugs that focus on improved safety and efficacy. The above factors are demanding R&D focus among the pharmaceutical companies. Therefore, compelling the market participants to effectively understand the key market dynamics, competitive scenario, drug pipeline and market forecast, to have a holistic perspective of the breast cancer drugs market.

INFORMATION SOURCES

Each of the section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for various geographic regions covering sub segments and micro markets. In addition the report also provides about 40 company profiles. Key market developments will be sourced from the top companies that are profiled. Secondary research will progress through both paid and unpaid sources. We will conduct primary research to provide in-depth understanding of the market.

1. Market Overview
   1.1. Breast cancer introduction (causes of cancer, types & therapies) 
   1.2. Breast cancer prevalence & incidence rates
   1.3. Improving survival rates
   1.4. Recent advancement in imaging technologies in cancer diagnostics
   1.5. R&D focus of pharmaceutical companies
   1.6. Increasing efforts to enhance awareness levels
   1.7. Developed nations vs. developing nations (diagnosis to therapeutics)
   1.8. Focus areas: conventional vs. novel drugs 
   1.9. Emerging avenues in cancer drugs market

2. Market Dynamics
   2.1. Drivers
   2.2. Restraints
   2.3. Challenges

3. Market Estimates (2009 to 2014)
   3.1. Sales (by Brand)
   3.2. Market Size

4. Market Structure (Market Dynamics, Market Estimates, Strategic Analysis)
   4.1. Chemotherapy Drugs
        4.1.1. Anthracyclines
               4.1.1.1. Adriamycin (doxorubicin)
               4.1.1.2. Ellence (epirubicin)
        4.1.2. Taxanes
               4.1.2.1. Taxol (paclitaxel)
                        4.1.2.1.1. Abraxane IV ( Paclitaxel Protein Bound Injection)
               4.1.2.2. Taxotere (docetaxel)
        4.1.3. Antimetabolites
               4.1.3.1. Adrucil (fluorouracil)
               4.1.3.2. Xeloda (capecitabine):
               4.1.3.3. Gemzar (gemcitabine) 
        4.1.4. Alkylating Agents - Cytoxan (cyclophosphamide)
        4.1.5. Epothilones - Ixempra (Ixabepilone)
   4.2. Hormone Therapy
        4.2.1. SERMs (Selective Estrogen-Receptor Modulators)
               4.2.1.1. Tamoxifen
               4.2.1.2. Evista (raloxifene)
               4.2.1.3. Fareston (toremifene)
        4.2.2. Aromatase Inhibitors
               4.2.2.1. Femara (letrozole)
               4.2.2.2. Arimidex (anastrozole)
               4.2.2.3. Megace (megestrol)
        4.2.3. Other Hormonal Therapies
               4.2.3.1. Zoladex (goserelin acetate)
               4.2.3.2. Faslodex (fulvestrant)
               4.2.3.3. Halotestin (Fluoxymesterone)
   4.3. Targeted Therapy
        4.3.1. Monoclonal Antibodies
               4.3.1.1. Avastin (Bevacizumab)
               4.3.1.2. Herceptin (Trastuzumab)
        4.3.2. Tyrosine kinase inhibitor - Tykerb (Lapatinib)

5. Pipeline Analysis
   5.1. Afinitor
   5.2. BSI-201
   5.3. NeuVax
   5.4. Stimuvax
   5.5. Custirsen Sodium (OGX-011)
   5.6. Others

6. Competitive Landscape
   6.1. Key strategies An analysis
   6.2. Market share
   6.3. Recent developments

7. Geographic Analysis
   7.1. North America
   7.2. Europe
   7.3. Asia
   7.4. ROW

8. Patent Analysis

9. Company Profiles
   9.1. Novartis AG
   9.2. Pfizer
   9.3. Oncogenex
   9.4. Apthera Inc
   9.5. Astellas
   9.6. BioNumerik Pharmaceuticals
   9.7. Oncothyreon Inc
   9.8. Bipar Sciences
   9.9. Others

Please fill in the form below to receive a free copy of the Summary of this Report



* First Name:



* Last Name:



* Job Title:



* Company:



* Email:



* Phone:



* Country:



  Do you have any Specific field of Interest?
(Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!)




Reports Interested in ::



Global Breast Cancer Drugs Market

* Enter the text from the image to the textbox :
4 2 2 0 7  


Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports